<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03838640</url>
  </required_header>
  <id_info>
    <org_study_id>5450-18-SMC</org_study_id>
    <nct_id>NCT03838640</nct_id>
  </id_info>
  <brief_title>Feasibility of Transnasal ECHO for Identification of Parapharyngeal Internal Carotid Artery</brief_title>
  <official_title>Feasibility of Transnasal ECHO for Identification of Parapharyngeal Internal Carotid Artery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identification and preservation of internal carotid artery during endoscopic
      nasopharyngectomy in cases of malignancy is a main difficulty of this kind of surgery,
      especially when anatomy is distorted by previous radiation. Intraoperative navigation based
      on preoperative imaging cannot remain precise throughout the process of resection. We aim to
      check a feasibility of internal carotid artery localization with the help of transnasal
      ultrasonic scanning. The most appropriate for this method existing device is an
      echocardiography system with pediatric transesophageal transducer.

      We plan to use it in 20 patients undergoing elective surgery for inflammatory sino-nasal
      disease. After initiatioin of general anesthesia and local decongestion, transducer will be
      placed transnasally to nasopharynx in order to scan a parapharyngeal space.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>distance from nasopharynx surface to a closest wall of internal carotid arter</measure>
    <time_frame>3 minutes</time_frame>
    <description>cm</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>To Assess Feasibility of the New Application</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consecutive eligible patients requiring endoscopic surgery for sinonasal pathology Transnasal localization of internal carotid artery with TEE ECHO device will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EPIQ 5</intervention_name>
    <description>As described in summary Trade name of the device Philips EPIQ 5</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Indication for endoscopic nose and paranasal sinuses surgery

        Exclusion Criteria:

        Previous nasopharyngeal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arkadi Yakirevitch, MD</last_name>
      <phone>972547808078</phone>
      <email>arkadiyak@gmail.com</email>
    </contact>
    <contact_backup>
      <email>arkadiyak@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Arkadi Yakirevitch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>December 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2019</study_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Arkadi Yakirevitch</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plans to share</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

